We used Cox proportional hazards models to examine the relationship between uric acid concentrations and blood pressure outcomes (incident hypertension and blood pressure progression by [greater than or equal to] 1 JNC VI category) during follow-up, adjusting for potential confounding factors.
7%) experienced an increase in blood pressure to a higher JNC VI stage (Table 2).
4] Nonstandard abbreviations: BMI, body mass index; GFR, glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; JNC VI, sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; RR, relative risk.
Table 5 Risk Stratification and Treatment of Hypertension: JNC VI
Recommendations * Blood Pressure Risk Group Risk Group B Risk Group C Stages (mm Hg) A ([dagger]) ([double dagger]) ([section]) High-normal LM LM DT and LM (130-139/85-89) Stage 1 LM (up to LM ([parallel] DT and LM (140-159/90-99) 12 months) (up to 6 months) Stages 2 and 3 DT and LM DT and LM DT and LM (160/100) JNC VI
= Joint National Committee on Prevention, Nutrition, Evaluation and Treatment of High Blood Pressure, Sixth Report ([dagger]) No risk factors; no target organ disease (TOD)/clinical cardiovascular disease (CCD).